Background: Shrimp allergy is considered a lifelong condition. The natural resolution of shrimp allergy is not well studied.
Introduction
The prevalence of food allergy was 8% and 5% in children adults, respectively. 1 This prevalence was increasing over the past 10-15 years, especially among infants and preschool children. 1 Common food allergens in infants and young children in Asia are milk, eggs and wheat with the prevalence of 0.83-5%, 3-4% and 0.08% respectively. Adults are more allergic to shellfish, fish and peanut with the prevalence of 7.05%, 1.17% and 0.48% respectively. [1] [2] [3] [4] Shellfish, especially shrimp, was a leading cause of food allergy among adolescents and adults. 3, [5] [6] [7] [8] In Asia, shellfish allergy was more common than peanut allergy which was in contrast to those in Western countries. 7, 9 A study from Singapore reported that sensitization to shellfish (77%) was higher than peanut (45%) among children greater than 4 years of age. 10 Moreover, shellfish was the leading cause of food-induced anaphylaxis, especially in Asian countries. 7, 8, 11, 12 In our previous study, 68 children with a history of shrimp allergy and skin tests positive to shrimp were orally challenged with Pm and Mr. 13 We found 12 patients who had allergy to Pm only, 16 patients to Mr only, and 32 patients to both shrimp species. Patients who had anaphylaxis, and 8 patients who had negative OFC to shrimp were excluded from the current study. The remaining 52 patients met the inclusion criteria and were invited to participate in this study. The flow of participants throughout the study is shown in Figure 1 .
Skin test procedure
Skin tests were performed using the previously described method. 13 In brief, SPT using Pm and Mr extracts (PmSPT and MrSPT), and prick-to-prick (PTP, pricking the food and then pricking the skin of the patients) method using cooked Pm and Mr (PmPTP and MrPTP) were performed. The P. monodon and M. rosenbergii extracts were freshly prepared by making a dilution of 1:10 (wt/volume) of raw lyophilized shrimp in Coca's solution. The sensitivity and specificity for PmSPT, PmPTP MrSPT and MrPTP were 97.73% and 8.33%, 100% and 4.17%, 97.92% and 5%, 100% and 0%, respectively. 13 The glycerinated saline and histamine phosphate 10 mg/mL were negative and positive controls, respectively. Antihistamines were discontinued for at least 7 days prior to skin testing. The mean of the largest and midpoint orthogonal diameters of wheals was recorded as the mean wheal diameter (MWD), and was considered positive if it was 3 mm larger than the negative control.
Oral food challenge procedure
OFC to Pm and/or Mr was performed in patients identified in our previous study as having allergy to Pm, to Mr, or to both shrimp species. 13 The open OFC protocol was modified from our and previous reports. 13, [22] [23] [24] The protocol comprised challenges in three steps, with multiple doses in two of the steps. Steps were performed 15 minutes apart. The provocation dose (PD) in the first step consisted of raw lyophilized shrimp in capsules which were given as follows: 500 mg, 1, 2, and 4 g given at 15-minute intervals. The cumulative PD was 7.5 g. The second step was to identify oral-mucosal reactions by swabbing 2 g of cooked shrimp onto the inner lips, placing it into the mouth without chewing for 5 minutes, and then removed. Lip itching/swelling and/or throat itching was recorded as a positive oral-mucosal reaction. The third step involved open feeding of cooked shrimp. The PD schedule of cooked shrimp was, as follows: 1, 2, 4, and 8 g at 15-minute intervals. The cumulative PD was 15 g. A positive response to one or more steps of the OFC was considered a positive challenge. Patients who had a positive reaction to both shrimp species were challenged 2-4 weeks later with other shrimp species. If the patient had no reaction to the OFC, a telephone follow-up was conducted 2-3 weeks later to inquire if the patient had any reaction to shrimp consumption. Anaphylaxis was diagnosed according to established criteria. 25 Patient symptoms and signs were recorded every 15 minutes during OFC.
Outcomes of shrimp OFC
Negative shrimp challenge was designated 'resolved shrimp allergy' (RSA), with a positive challenge designated 'persistent At least 2 studies reported allergy to specific shrimp species in a subset of shrimp allergic patients. 13, 14 During 2005-2006, we studied 68 children who had history of shrimp allergy and positive skin tests to shrimp. Using oral food challenges (OFC) to Penaeus monodon (Pm; saltwater shrimp) and Macrobrachium rosenbergii (Mr; freshwater shrimp), we identified specific allergy to Pm and Mr in 17.65% and 23.53% of children, respectively. Positive and negative OFC to both shrimp species was found in 47.06% and 11.76% of children, respectively. 13 A study from Singapore also confirmed species-specific shrimp allergy in adults who had positive OFC to Pm and Litopenaeus vannamei (Lv).
14 Shrimp allergens such as tropomyosin, arginine kinase, myosin light chain and sarcoplasmic calcium binding protein are well characterized in Pm and Lv. 15 The protein antigens in Mr were not widely studied since this shrimp is not available worldwide. Our group has characterized the cross-reactive tropomyosin and non-cross reactive hemocyanin in Mr. 16, 17 Unlike egg, wheat, soy, and cow's milk, peanut and shellfish allergy are regarded as lifelong allergies. 5, 18, 19 However, Ho, et al., followed children less than 2 years of age who had wheal size from skin prick test (SPT) to peanut ≥ 95% of positive predictive value (PPV) for up to 8 years. Peanut challenges were performed when SPT responses decreased to less than 95% PPV. They found that 21% of children with peanut allergy developed clinical tolerance by 5 years of age. 20 In addition, recent data from the HealthNuts study revealed that 22% of infants with challenge-proven peanut allergy developed peanut tolerance by 4 years of age. 21 Despite the findings that natural resolution of peanut allergy can occur, the natural course of shrimp allergy has not been well studied. The aim of this study was to investigate the natural resolution of shrimp allergy among a cohort of patients who were diagnosed as having non-anaphylactic shrimp allergy 10 years earlier by OFC, and to identify factors associated with shrimp tolerance.
Methods

Subjects
This prospective cohort included patients who were diagnosed with shrimp allergy to Pm, Mr, or both from a study that we conducted during 2005-2006. 13 The current study was conducted during 2015-2016. Both studies were conducted at the Division of Allergy and Clinical Immunology, Department of Pediatrics, Siriraj Hospital. This study was approved by the Siriraj Institutional Review Board (SIRB), (COA no. 017/2559, EC1). Written informed consent was obtained from all participants.
Due to the ethical concern, patients who had previous anaphylactic reaction to shrimp or recent allergic reaction after shrimp ingestion within the past 6 months, were not included. Patients with underlying diseases such as cardiovascular, hepatobiliary, and renal diseases; severe systemic infection; and/or pregnancy, were excluded. Patients with allergic diseases, such as asthma, allergic rhinitis, urticaria, and atopic dermatitis, were stable for more than 7 days before OFC. Peak expiratory flow rate was more than 70% of predicted value on the day of OFC. None of the patients were on β-blocking agents or systemic corticosteroid. Natural resolution of non-anaphylactic shrimp allergy shrimp allergy' (PSA). The outcome of this study was categorized into 3 outcomes as the following: Outcome 0: Patients had positive OFC to Pm only, Mr only, or both species in our previous report, 13 but, had negative shrimp OFC in the current study.
Outcome 1: Patients had positive OFC to Pm only or Mr only in our previous study, and still had positive OFC in the current study. Patients who had allergy to both shrimp species in the previous report 13 tolerated one shrimp species in the current study.
Outcome 2: Patients had positive OFC to both shrimp species in both the previous and current study.
Statistical analysis
Data are presented as mean ± standard deviation or median and range for continuous data, and as number and percentage for categorical data. Pearson's chi-square test and Fisher's exact test were used to analyze categorical data. Comparisons between parameters of RSA and PSA groups were done using independent T-test or Mann-Whitney U test if the data were not normally distributed. A p-value ≤ 0.05 was considered significant.
Results
Subjects
Of the 52 patients who met the inclusion criteria, 6 had allergic reaction to shrimp ingestion within the past 6 months, 9 refused to participate and 20 could not be contacted. The remaining 17 patients were recruited. Three patients had isolated allergy to Pm, 3 had isolated allergy to Mr, and 11 had allergic reaction to both shrimp species (Figure1, Tables 1 Therefore, RSA was found in 1/3 of the patients who were previously allergic to Pm, and in 3/3 of the patients who were previously allergic to Mr. In patients who were previously allergic to both Pm and Mr, RSA to both shrimp species was found in 3/9 patients.
Overall, there were 26 challenges. Six of 13 (46%) challenges to Pm and 6/13 (46%) challenges to Mr, were negative. The mean onset of allergic reactions after OFC was 7.50 (range 1-120) minutes. The most common allergic reactions were found on the skin and soft tissue (85.7%), followed by gastrointestinal (21.4%) and respiratory system (14.3%). Anaphylaxis was found in 3 patients who were previously allergic to both shrimp species.
Fifteen patients who completed the challenge protocol, were divided into 3 outcome categories since some patients with dual shrimp allergy had RSA to one shrimp species but PSA to another species. Seven (46.6%) patients (P1, M1-M3, B1-B3 in Table 1 ) had RSA, and were designated as having 'Outcome 0' . Four (26.7%) patients (P2-P3, B4-B5 in Table 1 ) had PSA to one shrimp species, and were designated as having 'Outcome 1' . Four (26.7%) patients (B6-B9 in Table 1 ) had PSA to both shrimp species, and were designated as having 'Outcome 2' . Factors investigated for the association with these outcomes are listed in Table 2 . No factors were found to significantly associate with RSA. The age at diagnosis of shrimp allergy was not a significant predictor of outcome (data not shown).
Demographic data, personal and family history of atopy, other food allergy besides shrimp, route of exposure, symptoms and onset of shrimp allergy in the past, are shown in Table 2 . Underlying allergic diseases, such as asthma, allergic rhinitis, and atopic dermatitis, were found in 76.5% of patients. Allergic reaction to other food, such as crab, mollusks, or fish, was found in 82.4% of patients.
Results of shrimp OFC
In this study, 1 of the 3 patients (patient's number P1 in Table 1 ) who were previously diagnosed as having isolated allergy to Pm had negative challenges to Pm (Figure 1, Table  1) . All of the patients (M1-M3) who were previously diagnosed as having isolated allergy to Mr had negative challenges to Mr (Figure 1, Table 1 ).
Eleven patients who were allergic to both shrimp species were scheduled for re-challenge to both shrimp species. However, 2 patients (B10, B11) refused to participate in the 2 nd challenge after having an allergic reaction to the 1 st challenge (Figure 1, Table 1 ). Therefore, in this group of dual allergy, 10 challenges to Pm and 10 to Mr were done. Of the 9 patients who had complete OFC to both shrimp species, 3 patients had negative challenges to both species (B1-B3). Two patients had negative challenges to Pm but positive challenges to Mr (B4-B5). Four patients had positive challenges to both Pm and Mr (B6-B9). A telephone follow-up was conducted to inquire if patients with negative challenge developed any allergic reaction upon shrimp consumption. Those follow-up calls revealed no allergic reactions in patients with negative OFC in the current study.
Results of skin tests
The results of PmSPT, PmPTP, MrSPT, and MrPTP from included patients are shown in Table 1 . These skin test results were compared with the results from the previous study in the same patients. 13 The median MWD of PmSPT in the previous and current studies was 12. The data of skin tests from our previous study 13 in the same patients included in the current study are shown in Figure 2A . The median MWD for PmSPT, PmPTP, MrSPT and MrPTP in patients with RSA were significantly smaller than those in patients with PSA. In the current study, median MWD for PmSPT, PmPTP, MrPTP in patients with RSA were significantly smaller than those in patients with PSA. However, median MWD of MrSPT was not significantly different between RSA and PSA groups. (Figure 2B ).
In patients with Pm allergy, the PmSPT MWD decreased 18.0% (range: -233.3-80.0%) from the data obtained from the previous study in the RSA group, and decreased 29. Skin test size in the current study showed a declining trend compared to the same patients in our previous report. 13 However the decrease was only statistically significant for MrSPT. This finding is in support of Ayuso, et al., who suggested that IgE sensitivity to shrimp decreases over time. 27 Factors other than specific food antigens that predict persistent food allergy have been reported. 28 These factors include more severe symptoms upon antigen ingestion, lower PD, presence of allergic comorbidities, adult onset, greater SPT MWD, higher food sIgE, and persistent SPT reactivity or food sIgE over time. 1, [19] [20] [21] [28] [29] [30] [31] [32] [33] Ho, et al. reported that 21% of children with peanut allergy became tolerant by the age of 5 years. Skin prick test to peanut more than 6 mm before the age of 2 years was a predictor of persistent peanut allergy. 20 Peters, et al. found that 22% of children with peanut allergy developed tolerance by the age of 4 years. Skin prick test to peanut at 1 and 4 years of age predicted resolved or persistent peanut allergy at 4 years of age. 21 Our present study found smaller skin test sizes in patients with RSA compared to patients with PSA (except for MrSPT) in both the current study and the study we conducted 10 years ago.
The strength of this study is a long-term study and the RSA is proven by OFC. This study has some mentionable limitations. A number of patients were either lost to follow-up or refused to participate since most of them were in adult ages and changed their addresses or would not want to miss their works. Patients with anaphylaxis or recent allergic reaction to shrimp were excluded since they were not allowed to participate by the ethic committee. In general, these patients were not considered shrimp challenge in the real allergy practices.
In conclusion, 46% of shrimp allergic patients had RSA at ten years after diagnosis. Moreover, RSA patients had significantly smaller MWD than PSA patients at both diagnosis and at the ten-year follow-up.
Discussion
Understanding the natural history of shrimp allergy helps physicians to determine whether or not and when rechallenge of shrimp is appropriate. Shrimp allergy has long been considered lifelong, and patients have generally been instructed to strictly avoid shrimp.
Daul, et al. investigated the natural history of shrimp hypersensitivity and found that 7 of 11 shrimp hypersensitive patients had positive shrimp challenges. 26 The shrimp-specific lgE (sIgE) of all subjects were stable during the 24-month period and the authors concluded that shrimp hypersensitivity was a persistent condition. In contrast, Ayuso, et al. studied IgE-binding to specific epitopes of 4 shrimp allergens in children and adults with immediate allergic reactions to shrimp. 27 Children with shrimp allergy had higher shrimp sIgE, and more intense IgE binding to all shrimp peptides and to more diverse epitopes than adults. These findings suggest a decline in sIgE and the possible waning of shrimp allergy overtime.
The current study followed patients with shrimp allergy 10 years earlier, and re-challenged them to shrimp. We identified RSA in 7/15 (46%) patients who previously had allergy to either Pm, Mr, or both shrimp species. To our knowledge, this is the first study to demonstrate the resolution of shrimp allergy by performing follow-up challenges in patients who had challenge-proven shrimp allergy.
